---
category: trading
circular_id: 46c4584c12a0cd50
date: '2025-12-10'
description: 'BSE revokes the suspension in trading of equity shares of Vivimed Labs
  Ltd (Scrip Code: 532660), allowing resumption of trading on the exchange.'
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={619F0115-D16A-4EFB-9453-946EE60A47FC}&noticeno=20251210-26&dt=12/10/2025&icount=26&totcount=78&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Revocation of trading suspension directly impacts trading activity
  and investor access to Vivimed Labs equity shares, restoring normal market operations
  for the scrip
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251210-26&attachedId=dddbf0c7-7976-48a2-a472-a5e79fb3ed2d
processing:
  attempts: 1
  content_hash: e071c4f26757ee4a
  processed_at: '2025-12-10T18:57:22.965501'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-10T11:05:26+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={619F0115-D16A-4EFB-9453-946EE60A47FC}&noticeno=20251210-26&dt=12/10/2025&icount=26&totcount=78&flag=0
severity: high
source: bse
stocks:
- VIVIMED
tags:
- trading-suspension
- revocation
- vivimed-labs
- equity-shares
- market-operations
- scrip-532660
title: Revocation of Suspension in Trading of Equity Shares of Vivimed Labs Limited
---

## Summary

BSE has revoked the suspension in trading of equity shares of Vivimed Labs Limited (Scrip Code: 532660). This action allows the resumption of normal trading activities for the company's equity shares on the BSE platform.

## Key Points

- Company: Vivimed Labs Limited
- Scrip Code: 532660
- Action: Revocation of trading suspension
- Exchange: BSE (Bombay Stock Exchange)
- Circular Date: December 10, 2025
- Trading to resume with immediate effect

## Regulatory Changes

The suspension previously imposed on Vivimed Labs Ltd equity shares has been lifted. Trading in the scrip is now permitted on the BSE platform, restoring normal market operations.

## Compliance Requirements

- Market participants can resume trading in Vivimed Labs equity shares
- Standard trading rules and regulations apply
- Brokers and investors should update their systems to reflect the revocation

## Important Dates

- Circular Date: December 10, 2025
- Effective Date: Immediate (from date of circular)

## Impact Assessment

**Market Impact:** High - The revocation allows investors to buy and sell Vivimed Labs shares, restoring liquidity and price discovery for the scrip.

**Investor Impact:** High - Shareholders regain the ability to trade their holdings, which was previously restricted during the suspension period.

**Operational Impact:** Trading members and market participants can now accept and execute orders for Vivimed Labs equity shares through the BSE platform.